Literature DB >> 17960052

Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension.

Sebastiaan Holverda1, Harm J Bogaard, H Groepenhoff, Pieter E Postmus, Anco Boonstra, Anton Vonk-Noordegraaf.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) is a well-known complication of chronic obstructive pulmonary disease (COPD). It remains unclear whether exercise parameters can be used to discriminate between COPD patients with associated PH (COPD-PH) and COPD patients without associated PH (COPD-nonPH).
OBJECTIVE: To study whether the existence of pulmonary hypertension in COPD is related to characteristic findings in gas exchange and circulatory parameters during cardiopulmonary exercise testing (CPET).
METHODS: We retrospectively analyzed CPET data in 25 COPD patients in whom right heart catheterization had been performed. Differences were assessed between COPD-PH and COPD-nonPH patients in peak oxygen uptake (VO(2) peak), ventilatory efficiency (VE/VCO(2)), oxygen pulse, maximal ventilation and pulse oximetry (S(p)O(2)).
RESULTS: PH was found in 10 of 25 patients (mP(pa) = 33 +/- 7 mm Hg), in 15 patients mean pulmonary artery pressure (mP(pa)) was below 25 mm Hg (18 +/- 3 mm Hg). CPET in COPD-PH was characterized by a higher VE/VCO(2) at nadir, a higher VE/VCO(2) slope, and a lower S(p)O(2) at rest and during exercise, but values in both groups were overlapping considerably. In the whole group mP(pa) was associated with resting P(a)O(2) (r = -0.70, p < 0.001), VE/VCO(2) nadir (r = 0.43, p < 0.05), and inversely related to S(p)O(2) at rest and during exercise (r = -0.58 and r = -0.64, p < 0.01, respectively).
CONCLUSION: Although CPET characteristics showed a large overlap in both groups, the existence of PH in COPD is associated with a significantly reduced ventilatory efficiency during CPET. However, a low S(p)O(2) at rest and a further decrease during exercise similarly suggest the presence of PH in COPD. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17960052     DOI: 10.1159/000110207

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  24 in total

Review 1.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

2.  Walk-run transition in young and older adults: with special reference to the cardio-respiratory responses.

Authors:  P T V Farinatti; W D Monteiro
Journal:  Eur J Appl Physiol       Date:  2010-02-03       Impact factor: 3.078

3.  Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers.

Authors:  Aaron W Trammell; Meredith E Pugh; John H Newman; Anna R Hemnes; Ivan M Robbins
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

4.  Ventilatory efficiency slope as a predictor of suitability for surgery in chronic obstructive pulmonary disease patients with lung cancer.

Authors:  Mathew Suji Eapen; Ravneet Grover; Kiran Ahuja; Andrew Williams; Sukhwinder Singh Sohal
Journal:  Ann Transl Med       Date:  2016-08

5.  Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis.

Authors:  Laura Fossati; Séverine Müller-Mottet; Elisabeth Hasler; Rudolf Speich; Konrad E Bloch; Lars C Huber; Silvia Ulrich Somaini
Journal:  Lung       Date:  2014-10-28       Impact factor: 2.584

Review 6.  Right ventricular dysfunction in chronic lung disease.

Authors:  Todd M Kolb; Paul M Hassoun
Journal:  Cardiol Clin       Date:  2012-05       Impact factor: 2.213

7.  Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD.

Authors:  Karin Vonbank; Georg Christian Funk; Beatrice Marzluf; Bernhard Burian; Rolf Ziesche; Leopold Stiebellehner; Ventzislav Petkov; Paul Haber
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

8.  Chronotropic incompetence predicts mortality in severe obstructive pulmonary disease.

Authors:  José González-Costello; Hilary F Armstrong; Ulrich P Jorde; Anna C Bevelaqua; Laurie Letarte; Byron M Thomashow; Matthew N Bartels
Journal:  Respir Physiol Neurobiol       Date:  2013-05-10       Impact factor: 1.931

9.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

10.  Comparison of Functional Capacity and Symptoms of COPD Patients with and without Pulmonary Hypertension.

Authors:  Fikriye Kalkan; Elif Yilmazel Ucar; Kamuran Kalkan; Omer Araz
Journal:  Eurasian J Med       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.